Applications published 13 June 2007
Novel compsn for xerostomia
Glaxo Group; GlaxoSmithKline Consumer Healthcare 1793799*
Skin cooling compsns
Kimberley-Clark Worldwide 1793800*
Novel granulation process and granulate produced therefrom
Teva Pharmaceutical Industries 1793801*
Controlled and directed local delivery of anti-inflammatory compsns
Warsaw Orthopaedic 1793802*
Conveniently implantable sustained release drug compsns
Ramscor 1793803*
Use of liposomal glucocorticoids for treating inflammatory states
Yissum Research Development Company of the Hebrew University of Jerusalem; Hadasit Medical Research Services & Development 1793804*
Liposomal formulations comprising an amphipathic weak base like tempamine for treatment of neurodegenerative conditions
Yissum Research Development Company of the Hebrew University of Jerusalem; Hadasit Medical Research Services & Development 1793805*
Pharmaceutical formulations containing vitamin E TPGS molecules that solubilise lipophilic drugs without significant efflux inhibition, and use of such formulations
Eastman Chemical 1793806*
Multifunctional supramolecular hydrogels as biomaterials
The Hong Kong University of Science and Technology 1793807*
Solid unit dosage forms of 5-HT1 agonist
Aurobindo Pharma 1793808*
Modified release ibuprofen dosage form
Scolr Pharma 1793809*
Nanoparticles and method for the production thereof
Gelita 1793810*
Antibiotic compound
Merck 1793812*
Treatment of ADHD
Ketocytonyx 1793813*
Thyroid hormone analogues for promoting angiogenesis
Ordway Research; Albany College of Pharmacy 1793814*
Amorphous atorvastatin calcium
Dr Reddy's Laboratories Ltd; Dr Reddy's Laboratories, Inc 1793815*
Compsns for treating amyloid associated diseases
Tel Aviv University Future Technology Development 1793816*
Methods of treating a disorder
Elixir Pharmaceuticals 1793817*
Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder
Neurocure 1793818*
Carbazole and cyclopentindole derivatives to treat infection with hepatitis C virus
Wyeth 1793819*
Ligand-dependant activation of NUR77 and uses thereof
The Texas A&M University System 1793820*
Pyrazolone compounds for treating cerebrovascular disorders
Mitsubishi Pharma 1793821*
Tricyclic, their manufacture and use as pharmaceutical agents
F Hoffmann-La Roche 1793822*
Sulphonyl hydrazines as hypoxia selective antineoplastic agents
Vion Pharmaceuticals 1793823*
New pharmaceutical compsns comprising 4-(4-(3-(4-chloro-3-trifluoromethyl-phenyl)-ureido)-3-fluoro-phenoxy)-pyridine-2-carboxylic acid for the treatment of hyper-proliferative disorders
Bayer Pharmaceuticals 1793824*
Chemical compounds
SmithKline Beecham 1793825*
Chemical compounds
Glaxo Group 1793826*
Tricyclic anilide spirolactam CGRP receptor antagonists
Merck 1793827*
Fibrate compounds having PPAR agonist activity
Dr Reddy's Laboratories Ltd; Dr Reddy's Laboratories Inc 1793828*
Use of pharmaceutical compsns of lofepramine for the treatment of ADHD, CFS, FM and depression
Neurocure 1793829*
Therapeutic combinations comprising poly(ADP-ribose) polymerases inhibitor
Pfizer; Cancer Research Technology 1793830*
Method of treatment for or protection against lymphedema
Bionumerik Pharmaceuticals 1793831*
Geranylgeranyl pyrophosphate synthase inhibitors
University of Iowa Research; Wiemer, David; Hohl, Raymond 1793832*
Multiple sclerosis treatment
Vasogen Ireland 1793833*
Indolin-2-one pyridine derivatives, preparation and therapeutic use thereof
Sanofi-Aventis 1793834*
Small interfering RNAs that efficiently inhibit viral gene expression and methods of use thereof
Somagenics 1793835*
Ophthalmic compsns including lubricant, deturgescent agent, and glycosaminoglycan and methods of using the same
Lindstrom, Richard 1793836*
Fatty acid modified polyllysines as antimicrobial agents
Technion Research & Development Foundation 1793837*
Amphiphilic polynorbornene derivatives and methods of using the same
Polymedix 1793838*
The use of winter savory (Satureja montana) or the extracts thereof for the preparation of medicaments for the treatment of the premature ejaculation
Indena 1793840*
Peptide inhibitors of C-jun dimerisation and uses thereof
Phylogica 1793841*
Treatment of cancer-related fatigue
Winokur, Andrew; Prange, Arthur; Yarborough, George 1793842*
Macrocyclic SH2 domain binding inhibitors
Government of the United States of America, Represented by the Secretary, Department of Health and Human Services 1793843*
Use of [D-meala]3-[etval]4-cyclosporin for the treatment of hepatitis C infection and pharmaceutical compsn comprising said [D-meala]3-[etval]4-cyclosporin
Debiopharm 1793844*
Use of IL-28 and IL-29 to treat cancer
ZymoGenetics 1793845*
Compsns and methods comprising vitamin B12 and an IMPDH inhibitor for treating viral, inflammatory and proliferative diseases
Transition Therapeutics 1793846*
Use of microproteins as tryptase inhibitors
NascaCell IP 1793847*
Method for determining dosage for an oral killed vaccine
Hunter Immunology 1793848*
Immunogenic compsn for use in vaccination against staphylococcei
GlaxoSmithKline Biologicals 1793849*
Antibodies against and methods for producing vaccines for respiratory syncytial virus
Medimmune 1793850*
Methods and compsns for treatment of haematologic cancers
Viralytics 1793851*
Inactivated poliomyelitis vaccine derived from sabin strain of polio virus
Panacea Biotec 1793852*
Liquid allergy vaccine formulation for oromucosal administration
Alk-Abello 1793853*
Treating gliosis, glial scarring, inflammation or inhibition of axonal growth in the nervous system by modulating EPH receptor
The University of Queensland; The University of Melbourne 1793854*
Prevention and treatment of synucleinopathic and amyloidogenic disease
Elan Pharmaceuticals; The Regents of the University of California 1793855*
Methods and compsns for treating allergic inflammation
Amgen 1793856*
Combination therapy with anti-CTLA4 and anti-4-1BB antibodies
The Ohio State University Research Foundation 1793857*
Human monoclonal anti-CTLA4 antibodies in cancer treatment
The Ohio State University Research Foundation 1793858*
Methods of healing wounds by administering human IL-18
SmithKline Beecham 1793859*
Compsn and method for medical imaging of body cavities
GynaecologlQ 1793860*
An antimicrobial silver halide compsn
Eastman Kodak 1793861*
A process for the preparation of a piroxicam: betacyclodextrin inclusion compound
Chiesi Farmaceutici 1793862*
Nanoparticles comprising antigens and adjuvants and immunogenic structure
Midatech; Igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs 1793863*
Method of treating an inflammatory disease by double stranded ribonucleic acid
Nastech Pharmaceutical 1793864*
Gene or drug delivery system
Baylor Research Institute; Board of Regents, The University of Texas System 1793865*
Luminescent metal complexes for monitoring renal function
Mallinckrodt 1793866*